Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine M Wolfrum

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|September 26, 2025
(N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N<sup>6</sup> groups for bitopic stabilizationDilip K Tosh, Matteo Pavan, Laura B Kozell, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2024
Pharmacologic Characterization of Substituted Nitazenes at <i>μ</i>, <i>κ</i>, and <i>Δ</i> Opioid Receptors Suggests High Potential for ToxicityLaura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
ACS Pharmacology & Translational Science|January 15, 2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved DrugsRebecca Racz, Laura B Kozell, Amy J Eshleman, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|September 26, 2025
(N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N<sup>6</sup> groups for bitopic stabilizationDilip K Tosh, Matteo Pavan, Laura B Kozell, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2024
Pharmacologic Characterization of Substituted Nitazenes at <i>μ</i>, <i>κ</i>, and <i>Δ</i> Opioid Receptors Suggests High Potential for ToxicityLaura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
ACS Pharmacology & Translational Science|January 15, 2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved DrugsRebecca Racz, Laura B Kozell, Amy J Eshleman, et al.
Pageof 2